Formate-dependent Regulation of Cancer Metastasis
This project aims to elucidate the role of formate overflow in cancer metastasis and develop targeted therapies by investigating mitochondrial one-carbon metabolism and its signaling mechanisms.
Projectdetails
Introduction
Mechanisms underlying cancer metastasis are poorly understood and context dependent. An essential feature of disseminating cancer cells is metabolic plasticity, which allows cellular adaptation to changing environmental conditions along the metastatic cascade.
Discovery of Formate Overflow
I discovered in 2016 the phenomenon of formate overflow, an alternative pathway for serine catabolism via folate-mediated one-carbon (1C) cycle. Instead of using formate for nucleotide synthesis (to support proliferation), formate overflow is characterised by formate excretion from cancer cells.
Impact on Cancer Metastasis
Furthermore, I have convincingly demonstrated that mitochondrial 1C metabolism and increased extracellular formate concentrations promote cancer metastasis in a growth-independent manner. However, it remains unknown which intermediates of 1C metabolism contribute to this phenotype, how formate controls metastasis, and how it can be targeted therapeutically.
Research Objectives
To cross the current edge of knowledge, I will:
- Take advantage of genetic and newly developed analytical methods to dissect how the formate-dependent effects are propagated in cells.
- Describe intrinsic mechanisms to explain how the formate signal is relayed to promote metastasis.
- Exploit formate overflow for cancer cell killing by directly targeting the formate molecule.
Novel Concept and Tool Development
4M8 will explain a novel concept of how a mitochondrial metabolic signal drives cancer cells towards a pro-metastatic phenotype and how this knowledge can be translated into a signature to analyse the metabolic state in human tumour samples.
Conclusion
Finally, we will develop a novel tool to target formate directly within cancer cells. In sum, our research will shed light on an unexplored field of cancer metabolism, providing the foundation to develop novel treatment approaches against metastatic cancer, the primary cause of cancer death.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.000.000 |
Totale projectbegroting | € 2.000.000 |
Tijdlijn
Startdatum | 1-5-2024 |
Einddatum | 30-4-2029 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- LUXEMBOURG INSTITUTE OF HEALTHpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
MANUNKIND: Determinants and Dynamics of Collaborative ExploitationThis project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery. | ERC STG | € 1.497.749 | 2022 | Details |
Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressureThe UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance. | ERC STG | € 1.498.280 | 2022 | Details |
Uncovering the mechanisms of action of an antiviral bacteriumThis project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function. | ERC STG | € 1.500.000 | 2023 | Details |
The Ethics of Loneliness and SociabilityThis project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field. | ERC STG | € 1.025.860 | 2023 | Details |
MANUNKIND: Determinants and Dynamics of Collaborative Exploitation
This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.
Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure
The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.
Uncovering the mechanisms of action of an antiviral bacterium
This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.
The Ethics of Loneliness and Sociability
This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Intercellular trading in nucleotide metabolism: an emerging targetThis project aims to identify nucleotide sources and metabolic interactions in cancer and stromal cells using single-cell multi-omics to develop targeted therapies against nucleotide-dependent tumors. | ERC STG | € 1.450.000 | 2022 | Details |
Targeting the Metabolic Dependencies of Metastatic Tumor CellsThis project aims to identify and target unique amino acid dependencies in metastatic melanoma cells to develop novel therapies that prevent metastasis and improve cancer treatment outcomes. | ERC STG | € 1.493.750 | 2024 | Details |
Targeting Mfrn2 to Inhibit Metastatic CancersThis project aims to evaluate a solute carrier transporter as a drug target to inhibit metastatic growth in breast cancer, utilizing patient samples and mouse models for comprehensive analysis. | ERC POC | € 150.000 | 2023 | Details |
Deciphering METAstasis of lung cancer to BRAIN and developing new therapeutic approaches via a human metastatic cascade platformMETA-BRAIN aims to develop a human-based in vitro model to study cancer brain metastasis, the role of the blood-brain barrier, and create targeted drug delivery systems for effective treatment. | ERC STG | € 1.500.000 | 2024 | Details |
Intercellular trading in nucleotide metabolism: an emerging target
This project aims to identify nucleotide sources and metabolic interactions in cancer and stromal cells using single-cell multi-omics to develop targeted therapies against nucleotide-dependent tumors.
Targeting the Metabolic Dependencies of Metastatic Tumor Cells
This project aims to identify and target unique amino acid dependencies in metastatic melanoma cells to develop novel therapies that prevent metastasis and improve cancer treatment outcomes.
Targeting Mfrn2 to Inhibit Metastatic Cancers
This project aims to evaluate a solute carrier transporter as a drug target to inhibit metastatic growth in breast cancer, utilizing patient samples and mouse models for comprehensive analysis.
Deciphering METAstasis of lung cancer to BRAIN and developing new therapeutic approaches via a human metastatic cascade platform
META-BRAIN aims to develop a human-based in vitro model to study cancer brain metastasis, the role of the blood-brain barrier, and create targeted drug delivery systems for effective treatment.